These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32405634)

  • 21. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery.
    Lungare S; Hallam K; Badhan RK
    Int J Pharm; 2016 Nov; 513(1-2):280-293. PubMed ID: 27633279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An RGD-modified hollow silica@Au core/shell nanoplatform for tumor combination therapy.
    Li X; Xing L; Hu Y; Xiong Z; Wang R; Xu X; Du L; Shen M; Shi X
    Acta Biomater; 2017 Oct; 62():273-283. PubMed ID: 28823719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted doxorubicin-loaded core-shell copper peroxide-mesoporous silica nanoparticles for combination of ferroptosis and chemotherapy of metastatic breast cancer.
    Nourollahian T; Taghavi S; Abnous K; Taghdisi SM; Nekooei S; Ramezani M; Alibolandi M
    Int J Pharm; 2024 Sep; 662():124487. PubMed ID: 39029634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior doxorubicin cellular delivery effect established by optically active mesoporous silica nanoparticles.
    Wang L; Yu D; Li D; Li J
    Drug Deliv Transl Res; 2024 Nov; 14(11):3163-3172. PubMed ID: 38381319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of enzymatic/redox-switching nanogates on mesoporous silica nanoparticles for anticancer drug delivery.
    Luo W; Xu X; Zhou B; He P; Li Y; Liu C
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():855-861. PubMed ID: 30948123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
    Baghbani F; Moztarzadeh F
    Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
    Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
    Yuan X; Peng S; Lin W; Wang J; Zhang L
    J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden.
    Gao J; Fan K; Jin Y; Zhao L; Wang Q; Tang Y; Xu H; Liu Z; Wang S; Lin J; Lin D
    Eur J Pharm Sci; 2019 Dec; 140():105070. PubMed ID: 31518679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-Therapeutics-Loaded Mesoporous Silica Nanoparticles Applied for Breast Tumor Therapy.
    Li X; He G; Jin H; Tao J; Li X; Zhai C; Luo Y; Liu X
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46497-46503. PubMed ID: 31738505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
    Li X; Xie C; Xia H; Wang Z
    Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.